Sector Scinai Immunotherapeutics Ltd.

Aandelen

SCNI

US09073Q4029

Biotechnologie & Medisch Onderzoek

Geschatte realtime 19:39:58 02-11-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,4590 USD -2,67% Intraday-grafiek van Scinai Immunotherapeutics Ltd. -15,05% -93,54%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-2,67%-15,05%-65,41%-83,15%-93,54%-96,38%-99,34%-99,98%-99,99% 269K
-2,37%-4,19%-17,14%+7,96%+52,97%+39,49%+63,21%+6,51% - 63,77 mld.
-2,87%+0,49%-3,85%+8,56%+9,38%+10,45%+69,18%+187,28%+5.843,90% 56,37 mld.
+0,62%+2,11%+14,60%+15,71%+20,53%+20,22%+102,56%-16,43%+256,15% 54,62 mld.
-2,08%-4,04%+1,68%+12,51%+16,48%+22,76%+37,85%+1,83%+262,84% 44,06 mld.
-2,05%-1,74%+1,77%+16,14%+19,95%+16,85%+100,17%+1,70%+1.002,27% 42,11 mld.
-1,44%+3,14%-8,21%+3,96%+138,14%+219,70%+796,83%+495,92% - 41 mld.
-5,47%+24,76%+63,85%+100,33%+82,44%+98,34%+87,34%+27,30%+246,58% 34,92 mld.
+0,21%-1,23%+4,58%+2,84%+11,38%+14,81%+47,35%+13,64%+157,52% 32,82 mld.
-1,83%+18,45%-0,52%+12,29%-36,48%-40,64%+342,00%+245,13%+820,44% 24,7 mld.
+0,27%-2,62%-20,43%+15,13%+41,86%+23,20%-6,89%-60,00% - 23,27 mld.
-0,54%+0,94%-9,51%-4,95%-7,90%-15,66%-5,20%-69,71% - 22,15 mld.
+0,06%-3,74%+8,67%+13,63%+15,99%+9,67%+146,16%+187,19%+2.083,84% 18,24 mld.
-4,58%-3,13%+19,26%+49,91%+73,50%+93,50%+98,10%-19,88%+393,58% 17,16 mld.
+0,34%+2,37%+17,58%+29,94%+41,06%+46,26%+76,89%-16,01%+119,56% 17 mld.
+2,30%+9,08%+21,63%+28,99%+62,04%+86,60%+252,81%+224,59%+556,98% 16,93 mld.
-0,62%+2,27%+10,02%+2,98% - - - - - 16,5 mld.
-2,68%+12,29%+27,34%+30,27%+13,25%+22,26%-18,60%-26,92%+168,66% 15,83 mld.
0,00%+2,59%+1,71%+12,26%+180,86%+165,07%+345,26%+1.394,79%+769,37% 15,11 mld.
+9,29%+20,09%+5,25%+75,15%+36,59%-9,08% - - - 13,03 mld.
Gemiddelde -0,78%+4,35%+3,64%+17,52%+35,71%+38,28%+135,32%+137,61%+898,69% 28,48 mld.
Gewogen gemiddelde per kap. -1,25%+4,80%+4,96%+19,63%+40,01%+44,85%+147,63%+115,43%+1.286,96%
  1. Beurs
  2. Aandelen
  3. Koers SCNI
  4. Sector Scinai Immunotherapeutics Ltd.